← Evidence map

ArticleFrontiers in pharmacology2013

Erlotinib resistance in lung cancer: current progress and future perspectives.

Joy Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

39 papers cite it

2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 23407898